This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy (opens in a new window).
| Department | Department of Medical Oncology |
|---|
Through my experience at the MD Anderson Cancer Center and the National Cancer Center Japan, I have met many cancer researchers and oncologists from many countries. I believe that a wide range of international collaboration is essential to promote cancer research. Cancer care is advancing day by day. Our team will work to establish and promote cancer research network in Asia and contribute to improve cancer treatment in Asia.
Since I came to National Cancer Center, I have expanded my research to include clinical trial and translational research. I am participating in phase 2 and phase 3 clinical trials at the medical oncology department and early drug development at the phase 1 unit. I currently serve as head of The International Translational Research section at National Cancer Center Hospital and work on genomics research.
| 2020-present | Head of Physician at Dept. of Medical Oncology at NCCH, Head of The International Translational Research section at Dept. of International Clinical Development at NCCH |
|---|---|
| 2019-present | Concurrent appointment at the Dept. of Experimental Therapeutics, NCCH |
| 2017-2020 | Staff physician, Dept. of Breast and Oncology at NCCH and Rare Cancer Center |
| 2012-2014 | Postdoctoral Fellow (Research), Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
| 2006-2012 | Resident and Chief resident, GI surgery, St. Luke’s International Hospital |